US10106850B2ExpiredUtilityA1

Method for high-throughput AFLP-based polymorphism detection

Assignee: KEYGENE NVPriority: Dec 22, 2005Filed: Aug 22, 2017Granted: Oct 23, 2018
Est. expiryDec 22, 2025(expired)· nominal 20-yr term from priority
C12Q 2600/156C12Q 1/6874C12Q 2600/16C12Q 1/6827C12Q 1/6869C12Q 1/6855C12Q 1/6883C12Q 1/6876C12Q 2565/301C12Q 2535/138C12Q 2535/122C12Q 2527/107
95
PatentIndex Score
8
Cited by
195
References
23
Claims

Abstract

The invention relates to a method for the high throughput discovery, detection and genotyping of one or more genetic markers in one or more samples, comprising the steps of restriction endonuclease digest of DNA, adaptor-ligation, optional pre-amplification, selective amplification, pooling of the amplified products, sequencing the libraries with sufficient redundancy, clustering followed by identification of the genetic markers within the library and/or between libraries and determination of (co-)dominant genotypes of the genetic markers.

Claims

exact text as granted — not AI-modified
The invention claimed is: 
     
       1. A method for detection of genetic variation in two or more members of a population, comprising:
 amplifying nucleic acid fragments of at least a first and second member of a population to obtain amplified nucleic acid fragments, wherein the amplified nucleic acid fragments of the first member of the population comprises sequences from a nucleic acid sample of the first member of the population and a first unique identifier sequence, wherein the amplified nucleic acid fragments of the second member of the population comprises sequences from a nucleic acid of the second member of the population and a second unique identifier sequence, and wherein the first and second unique identifier sequences indicate different sample origins of the nucleic acid fragments; 
 sequencing a pool of the amplified nucleic acid fragments using high throughput sequencing technology; 
 clustering the sequences of amplified nucleic acid fragments of the first and second members of the population and comparing the clustered sequences to a reference sequence to identify genetic variation; and 
 identifying the first and second member of the population as carrying the genetic variation using the first and second unique identifier sequences. 
 
     
     
       2. The method according to  claim 1 , wherein the amplifying step comprises amplifying by solution PCR. 
     
     
       3. The method according to  claim 1 , wherein the genetic variation comprises one or more SNP polymorphisms. 
     
     
       4. The method according to  claim 1 , wherein the genetic variation comprises one or more AFLP polymorphisms. 
     
     
       5. The method according to  claim 1 , wherein the sequencing is based on sequencing by synthesis. 
     
     
       6. The method according to  claim 5 , wherein the sequencing is pyrosequencing. 
     
     
       7. The method according to  claim 1 , wherein the sequencing is performed on a solid support. 
     
     
       8. The method according to  claim 7 , wherein the solid support is a bead. 
     
     
       9. The method according to  claim 8 , wherein the sequencing comprises:
 (1) annealing amplified nucleic acid fragments to beads, each bead annealing with a single nucleic acid fragment; 
 (2) emulsifying the beads in water-in-oil microreactors, each water-in-oil microreactor comprising a single bead; 
 (3) performing emulsion PCR to amplify the nucleic acid fragments on the surface of the beads; 
 (4) loading the beads in wells, each well comprising a single bead; and 
 (5) generating a pyrophosphate signal. 
 
     
     
       10. The method according to  claim 1 , wherein the reference sequence is a consensus sequence. 
     
     
       11. The method according to  claim 10 , wherein the consensus sequence is established from the population. 
     
     
       12. The method according to  claim 1 , wherein the reference sequence is a genomic sequence of a species of interest. 
     
     
       13. The method according to  claim 1 , wherein the reference sequence is from a sequence database. 
     
     
       14. The method according to  claim 1 , wherein the genetic variation is determined by sequencing with an average sequencing redundancy of at least 6. 
     
     
       15. The method according to  claim 1 , wherein the genetic variation is determined by sequencing with an average sequencing redundancy of at least 9. 
     
     
       16. The method according to  claim 1 , wherein the first and second unique identifier sequences are used for identifying the member carrying the genetic variation. 
     
     
       17. The method according to  claim 1 , wherein the detection of genetic variation is used for applications selected from the group consisting of genetic mapping, quantitative trait loci mapping, fine mapping genes/traits, linkage disequilibrium mapping, marker-assisted back-crossing, genetic distance analysis, discovery of makers linked to trait or phenotypes, and diagnostic genotyping of patient samples. 
     
     
       18. The method according to  claim 1 , wherein the nucleic acid samples of the first and second members of the population are DNA. 
     
     
       19. The method according to  claim 18 , wherein the nucleic acid samples of the first and second members of the population are mammalian DNA. 
     
     
       20. The method according to  claim 19 , wherein the nucleic acid samples of the first and second members of the population are human DNA. 
     
     
       21. The method according to  claim 1 , wherein the method further comprises restricting the nucleic acid samples using at least one restriction endonuclease to produce nucleic acid fragments. 
     
     
       22. The method according to  claim 1 , wherein the unique identifier sequence is introduced into the nucleic acid fragments by primer extension. 
     
     
       23. The method according to  claim 1 , wherein the unique identifier sequence is introduced into the nucleic acid fragments by adapter ligation.

Join the waitlist — get patent alerts

Track US10106850B2 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.